Some claims against Boston Scientific to proceed
455142
A federal judge has ruled that some product-liability claims against Boston Scientific Corp.  over implantable heart defibrillators can proceed, rejecting the medical device maker's motions to dismiss them.
93936
The concerns that have been raised about the safety of drug-eluting stents at a major cardiology conference shouldn't mean it's time to go back to older treatments, the chief medical and scientific officer of Natick medical technology company Boston Scientific Corp. said yesterday.
38641
An Oklahoma lawsuit filed on Thursday charges that Merck &amp; Co. misled patients about the safety of its arthritis drug. The case may signal many more such lawsuits against the drugmaker
169821
HAMISH ROBERTSON: Now to new claims this morning linking the deadly cancer mesothelioma to a commercial organisation. But in this case it&#39;s not James Hardie that&#39;s under the spotlight, but the Commonwealth Serum Laboratories.
243665
Stem cell researchers continue to question Advanced Cell Technology scientists on their increasingly contested paper published recently in Nature.. In Bodyhack.
459813
Time is running out for Boston Scientific to resolve what could be a multibillion-dollar liability resulting from its foray into the stent business.
36653
A trial that opened more than a year ago has become bogged down in Boston federal court. There have been hundreds of hours of testimony from witnesses, including 10 medical specialists paid tens of thousands of dollars. The judge himself even hired an expert to help him make sense of it all.
155100
Standard &amp; Poor's raised its outlook on Boston Scientific Corp. to positive from stable, citing its recovery of market share for its drug-coated Taxus cardiac stent after recalls that began in July. The debt rating agency said the upgrade reflects the Natick company's &quot;surprisingly rapid recovery&quot; of market share for Taxus, and its diverse product line. Last week, Boston Scientific ...
517153
Boston Scientific Corp. yesterday revealed details about the experimental drug-coated stent it acquired when it bought Guidant Corp. this year. The device will be called Promus, and the Natick medical device maker expects to start selling it in 2008.
38351
Boston Scientific agreed to pay $195 million to settle claims related to a potentially flawed defibrillator made by itâs subsidiary, Guidant.
64013
New reports accuse another drug company of being too slow to pull a dangerous medication from the market and question the ability of the federal Food and Drug Administration to protect the public from such risks.
318864
BIRMINGHAM, Ala. -- The defense in Richard Scrushy's corporate fraud trial sought to poke holes yesterday in the claims of a key witness who contends the fired HealthSouth chief executive was behind a scheme to overstate earnings.
253054
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist in Princeton, N.J., and has awarded the inventor $431 million in damages, Boston Scientific said Tuesday. The suit by the patent holder, Dr. Bruce N. Saffran, did not seek to halt sales of the stents.
494872
Boston Scientific Corp. , the state's largest life-science company, lost $3.6 billion last year thanks to its expensive acquisition of heart-device maker Guidant Corp. , and executives said yesterday they weren't certain when sales of its most important products would begin to recover from their slump.
520534
Eli Lilly may be close to resolving a government lawsuit over improper marketing.
79284
Investigation-raised questions lead computer maker to hold up regulatory filing; federal prosecutor begins a related probe.
148143
Johnson & Johnson JNJ.N has sued   Boston Scientific BSX.N and Abbott Laboratories Inc. ABT.N,   seeking at least $5.5 billion in damages related to J&J's   failed bid to acquire medical device maker Guidant Corp.